Key result
Hydrochlorothiazide at demonstrated a definite antihypertensive effect and biochemical changes, whereas doses of 3 and had no effect on blood pressure or metabolic parameters.
Why the study?
Does low-dose hydrochlorothiazide reduce blood pressure without adverse metabolic effects in patients with mild to moderate hypertension?
RCT (n=111)
Double-blind
Randomly allocated
Yes
Does low-dose hydrochlorothiazide reduce blood pressure without adverse metabolic effects in patients with mild to moderate hypertension?
Hydrochlorothiazide at 25 mg provides definite antihypertensive effects but causes metabolic changes, while doses of 3 and 6 mg are ineffective for blood pressure reduction.
Answers are grounded in this paper and cite their sources.
Low-dose hydrochlorothiazide lacks antihypertensive efficacy; challenges separability of dose-response curves for blood pressure reduction versus metabolic effects.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jounela et al. (1994) conducted an RCT in Mild to moderate hypertension (n=111). Hydrochlorothiazide vs. Placebo was evaluated on Blood pressure and biochemical variables. Hydrochlorothiazide at demonstrated a definite antihypertensive effect and biochemical changes, whereas doses of 3 and had no effect on blood pressure or metabolic parameters.
Synapse has enriched 10 related papers. Consider them for comparative context: